REGN - CHMP recommends Regeneron lymphoma antibody drug for conditional approval
2024-06-28 08:39:53 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
- Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea
- Regeneron wins injunction blocking Mylan from launching generic version of its eye drug Eylea (update)